Holen Sie sich die Stockscreener-App
1.015
0.49%
-0.005
Handel nachbörslich:
1.01
-0.005
-0.49%
Schlusskurs vom Vortag:
$1.02
Offen:
$1.02
24-Stunden-Volumen:
223.20K
Relative Volume:
0.82
Marktkapitalisierung:
$59.58M
Einnahmen:
$3.67M
Nettoeinkommen (Verlust:
$-13.83M
KGV:
-3.625
EPS:
-0.28
Netto-Cashflow:
$-10.79M
1W Leistung:
-1.46%
1M Leistung:
+6.71%
6M Leistung:
-17.48%
1J Leistung:
+35.99%
1-Tages-Spanne:
$1.01
$1.02
1-Wochen-Bereich:
$1.00
$1.04
52-Wochen-Spanne:
$0.48
$1.66
Icecure Medical Ltd Stock (ICCM) Company Profile
Firmenname
Icecure Medical Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ICCM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
1.015 | 61.62M | 3.67M | -13.83M | -10.79M | -0.28 |
|
ABT
Abbott Laboratories
|
124.42 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.78 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
387.32 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.70 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.56 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Icecure Medical Ltd Aktie (ICCM) Neueste Nachrichten
autocarpro> 2025> IceCure Medical Ltd Stock Analysis and ForecastPhenomenal trading returns - Autocar Professional
What drives IceCure Medical Ltd stock priceMarket-leading growth rates - Autocar Professional
What analysts say about IceCure Medical Ltd stockAccelerated profit realization - jammulinksnews.com
Is IceCure Medical Ltd a good long term investmentPhenomenal capital gains - jammulinksnews.com
IceCure Medical Ltd Stock Analysis and ForecastRobust financial gains - jammulinksnews.com
What institutions are buying IceCure Medical Ltd stock nowFree Exclusive Investment Tips - Newser
IceCure Medical schedules annual and special shareholder meeting for August 20 - Investing.com Nigeria
IceCure Medical Announces Shareholder Meeting for August 2025 - TipRanks
IceCure Medical schedules annual and special shareholder meeting for August 20 By Investing.com - Investing.com South Africa
Why IceCure Medical Ltd stock attracts strong analyst attentionMarket Beating Strategy - Newser
How IceCure Medical Ltd stock performs during market volatilityStable Stocks With High Yield - Newser
What makes IceCure Medical Ltd stock price move sharplyWeekly Big Movers - Newser
IceCure Medical (NASDAQ:ICCM) Downgraded by Wall Street Zen to “Sell” - Defense World
IceCure Announces Commencement of Rights Offering | ICCM Stock N - GuruFocus
DallasNews (DALN) to be acquired by Hearst for $14 cash per share | ICCM SEC FilingForm 6-K - Stock Titan
IceCure Announces Commencement of Rights Offering - Nasdaq
IceCure Medical Ltd's (NASDAQ:ICCM) Path To Profitability - simplywall.st
Head-To-Head Survey: IceCure Medical (NASDAQ:ICCM) versus Surgery Partners (NASDAQ:SGRY) - Defense World
IceCure Reports Preliminary Financial Results for the Three and Six Months Ended June 30, 2025 - Longview News-Journal
IceCure Medical Reports 24% Revenue Drop: Middle East Conflict Impacts Global Shipments - Stock Titan
IceCure Medical (NASDAQ:ICCM) shareholders have earned a 51% CAGR over the last five years - Yahoo.co
IceCure Medical Launches $10 Million Rights Offering - Finimize
IceCure Announces Record Date for Rights Offering for Up to $10 Million - Finansavisen
Cryoablation Probe Market Size, Share | Industry Report 2030 - Grand View Research
IceCure Medical takes another step towards a full patent application in US - Mugglehead Magazine
IceCure Medical (ICCM) Secures U.S. Patent for Cryogen Flow Cont - GuruFocus
IceCure Receives Notice of Patent Allowance in U.S. for a Novel Cryogen Flow Control to Optimize Patient Outcomes - GuruFocus
IceCure Medical (ICCM) Secures U.S. Patent for Cryogen Flow Control | ICCM Stock News - GuruFocus
IceCure Receives Notice of Patent Allowance in U.S. for a Novel - GuruFocus
IceCure Receives Notice of Patent Allowance in U.S. for a Novel Cryogen Flow Control to Optimize Patient Outcomes | ICCM Stock News - GuruFocus
H.C. Wainwright maintains Buy on IceCure Medical, target at $2.50 By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy on IceCure Medical, target at $2.50 - Investing.com Australia
Finanzdaten der Icecure Medical Ltd-Aktie (ICCM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.15%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):